Cargando…
Clinical efficiency of combination therapy using testosterone replacement therapy, phosphodiesterase 5 inhibitors and Kampo herbal medicine for eugonadal patients with late-onset hypogonadism syndrome
In the present study, the initial treatment efficiency of combination therapy using testosterone replacement therapy (TRT), herbal medicine and phosphodiesterase 5 inhibitors (PDE5i) in male patients with late-onset hypogonadism (LOH) were assessed. A total of 21 patients were enrolled and after 12...
Autores principales: | Takeuchi, Hisashi, Okubo, Hidenori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393732/ https://www.ncbi.nlm.nih.gov/pubmed/34504618 http://dx.doi.org/10.3892/etm.2021.10608 |
Ejemplares similares
-
The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
por: Shin, Yu Seob, et al.
Publicado: (2019) -
Who are the fair candidates for testosterone replacement therapy in patients with late-onset hypogonadism symptoms?
por: Amano, Toshiyasu
Publicado: (2023) -
Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy
por: Davidiuk, Andrew J., et al.
Publicado: (2016) -
Late-onset hypogonadism: beyond testosterone
por: Foresta, Carlo, et al.
Publicado: (2015) -
Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism
por: Almehmadi, Yousef, et al.
Publicado: (2016)